Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology--a rebuttal

J Thromb Haemost. 2005 Apr;3(4):816-7; author reply 817-8. doi: 10.1111/j.1538-7836.2005.01170.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Apoptosis*
  • Carboxymethylcellulose Sodium / chemistry
  • Cell Line, Tumor
  • Cell Size / drug effects
  • Cell Survival / drug effects
  • Dimethyl Sulfoxide / pharmacology
  • Doxorubicin / pharmacology*
  • Endothelial Cells / drug effects*
  • Endothelial Cells / pathology*
  • Endothelium, Vascular / cytology*
  • Humans
  • Solvents
  • Thalidomide / pharmacology*

Substances

  • Angiogenesis Inhibitors
  • Solvents
  • Thalidomide
  • Doxorubicin
  • Carboxymethylcellulose Sodium
  • Dimethyl Sulfoxide